An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica

[1]  N. Kuriyama,et al.  Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study , 2018, International journal of rheumatic diseases.

[2]  J. Gagné.  Literature Review , 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[3]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[4]  E. Matteson,et al.  Polymyalgia rheumatica , 2017, The Lancet.

[5]  A. Ogdie,et al.  Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population‐Based Study , 2017, Arthritis care & research.

[6]  T. Nanki,et al.  Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases , 2016, Metabolites.

[7]  T. Osaki,et al.  Application of Pre-Column Labeling Liquid Chromatography for Canine Plasma-Free Amino Acid Analysis , 2016, Metabolites.

[8]  J. Hutcheson.  Adipokines influence the inflammatory balance in autoimmunity. , 2015, Cytokine.

[9]  G. Frontera,et al.  The Association Between the Cardio-ankle Vascular Index and Other Parameters of Vascular Structure and Function in Caucasian Adults: MARK Study. , 2015, Journal of atherosclerosis and thrombosis.

[10]  J. Paterson,et al.  Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality , 2015, Annals of Internal Medicine.

[11]  K. Barraclough,et al.  2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative , 2015, Annals of the rheumatic diseases.

[12]  R. Quirce,et al.  (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica. , 2015, Revista espanola de medicina nuclear e imagen molecular.

[13]  L. Punzi,et al.  Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review , 2015, Expert opinion on drug safety.

[14]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2015, Kardiologia polska.

[15]  E. Rodríguez-Sánchez,et al.  Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: a case series report , 2015, Cardiovascular Diabetology.

[16]  A. Boonen,et al.  Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study , 2014, Annals of the rheumatic diseases.

[17]  S. Hider,et al.  Risk of vascular events in patients with polymyalgia rheumatica , 2014, Canadian Medical Association Journal.

[18]  S. Grundy,et al.  2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol. , 2014, Journal of the American College of Cardiology.

[19]  J. Gómez-Reino,et al.  Adipokines, Metabolic Syndrome and Rheumatic Diseases , 2014, Journal of immunology research.

[20]  S. Hider,et al.  Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis , 2013, European journal of preventive cardiology.

[21]  U. Müller-Ladner,et al.  Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases , 2013, Mediators of inflammation.

[22]  A. Larsson,et al.  Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study , 2013, Arthritis Research & Therapy.

[23]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[24]  E. Vicaut,et al.  Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) , 2012, Cerebrovascular Diseases.

[25]  S. Hider,et al.  Association between polymyalgia rheumatica and vascular disease: A systematic review , 2012, Arthritis care & research.

[26]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[27]  A. Iagnocco,et al.  2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. , 2012, Arthritis and rheumatism.

[28]  J. Aviña-Zubieta,et al.  Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies , 2012, Annals of the rheumatic diseases.

[29]  A. Iagnocco,et al.  2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative , 2012, Annals of the rheumatic diseases.

[30]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[31]  E. Mannarino,et al.  Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment , 2012, Annals of the rheumatic diseases.

[32]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[33]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[34]  M. Englund,et al.  Population‐based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis , 2011, Arthritis care & research.

[35]  U. Müller-Ladner,et al.  Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[36]  H. Galbo,et al.  Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica , 2010, Scandinavian journal of rheumatology.

[37]  D. Ouwens,et al.  The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease , 2010, Journal of cellular and molecular medicine.

[38]  S. Sakoda,et al.  Association of Inflammatory Markers and Carotid Intima-Media Thickness with the Risk of Cardiovascular Events in High-Risk Patients , 2010, Cerebrovascular Diseases.

[39]  M. Cutolo,et al.  Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica , 2010, Annals of the New York Academy of Sciences.

[40]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[41]  Hironori Yamasaki,et al.  Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[42]  G. Eknoyan,et al.  Adolphe Quetelet (1796-1874)--the average man and indices of obesity. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[44]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[45]  J. Higaki,et al.  Relationship between Cardio-Ankle Vascular Index (CAVI) and Carotid Atherosclerosis in Patients with Essential Hypertension , 2007, Hypertension Research.

[46]  S. Gabriel,et al.  Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. , 2007, Arthritis and rheumatism.

[47]  Kuniaki Otsuka,et al.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). , 2006, Journal of atherosclerosis and thrombosis.

[48]  S. Gabriel,et al.  Direct medical costs of polymyalgia rheumatica. , 2005, Arthritis and rheumatism.

[49]  E. Henze,et al.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study , 2004, Annals of the rheumatic diseases.

[50]  A. Hofman,et al.  Association Between Arterial Stiffness and Atherosclerosis: The Rotterdam Study , 2001, Stroke.

[51]  J. Slattery,et al.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) , 1998, The Lancet.

[52]  S. Gabriel,et al.  Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. , 1997, Arthritis and rheumatism.

[53]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[54]  A. Branwood,et al.  POLYMYALGIA RHEUMATICA BIOPSYSTUDIES , 1964 .

[55]  E. Matteson,et al.  Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies , 2016, Rheumatology International.

[56]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[57]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[58]  K. Liao,et al.  Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. , 2013, Rheumatology.

[59]  P. Kirchhof,et al.  The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) , 2013 .

[60]  D. Greenwood,et al.  Meta-analysis of Observational Studies , 2012 .

[61]  Takanobu Tomaru,et al.  Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[62]  J. Williams,et al.  IN A POPULATION-BASED CASE-CONTROL STUDY , 2001 .